drug
-
Franchise India Bureau Oct 24 2018 - 1 min readAstraZeneca will acquire a newly-issued equity stake of 9.8% in smaller French peer Innate Pharma. The acquisition will strengthen AstraZeneca's presence in the field of immuno-oncology. The British drugmaker will buy the stake via around 6.26 million new shares being issued to it at a price of 10 euros per share. Pascal Soriot, Chief Executive Officer of ...
-
Franchise India Bureau Oct 24 2018 - 0 min readCipla's South African subsidiary has acquired pharma firm Mirren (Pty) Ltd. Cipla Medpro South Africa (Pty) Ltd has completed the acquisition of 100% stake in South African firm Mirren. In July, Cipla had informed that its South African arm had signed an agreement to wholly acquire Mirren for a cash consideration of South African Rand ...
-
Franchise India Bureau Oct 24 2018 - 1 min readSun Pharmaceutical Industries Ltd has announced the launch of Ilumya (tildrakizumab-asmn), its plaque psoriasis treatment drug, in the United States (US) market. Ilumya in the strength of 100 mg/mL has been introduced in the US for the treatment of moderate-to-severe psoriasis. Abhay Gandhi, Sun Pharma North America CEO, said, "The availability of Ilumya is an ...
-
Franchise India Bureau Dec 02 2017 - 2 min readIn a stock-exchange disclosure Cipla Ltd said that, Cipla Holding B.V. has entered into an agreement with PharmaS to sell its 100% equity stake in Cipla Croatia for $1.1 million (Rs 7 crore). The buyer will pay $550,000 upfront and the remaining amount will paid in two tranches, on the first and second anniversary of ...
-
WI Bureau Sep 29 2017 - 1 min readA clinical trial in the US has received an experimental drug that aimed at treating a common liver disease with promising results. As per a report of leading business daily, The Economic Times, people with non-alcoholic steatohepatitis (NASH) who took obeticholic acid (OCA) had felt improved liver health during that duration, which also ...